New drug ABS-201 aims to tackle hair loss in men and women
Disease control
Recruiting now
This early-stage trial tests a new medication called ABS-201 to see if it is safe and tolerable for treating hair loss. It starts with healthy volunteers and then includes people with androgenetic alopecia (common baldness). Participants receive either ABS-201 or a placebo and ar…
Phase: PHASE1, PHASE2 • Sponsor: Absci Pty Ltd. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC